Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125650973 | 12565097 | 3 | F | 20160701 | 20160919 | 20160718 | 20160922 | PER | PHEH2016US017567 | NOVARTIS | 42.72 | YR | M | Y | 77.00000 | KG | 20160922 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125650973 | 12565097 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 1-2: 0.0625 MG (0.25 ML), QOD | Y | U | 125290 | .062 | MG | SOLUTION FOR INJECTION | |||||
125650973 | 12565097 | 2 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 3-4: 0.125 MG (0.5 ML), QOD | Y | U | 125290 | .125 | MG | SOLUTION FOR INJECTION | |||||
125650973 | 12565097 | 3 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 5-6: 0.1875 MG (0.75 ML), QOD | Y | U | 125290 | .187 | MG | SOLUTION FOR INJECTION | |||||
125650973 | 12565097 | 4 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 7+: 0.25 MG/250 UG (1 ML), QOD | Y | U | 125290 | .25 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125650973 | 12565097 | 1 | Multiple sclerosis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125650973 | 12565097 | Back pain | |
125650973 | 12565097 | Headache | |
125650973 | 12565097 | Influenza like illness | |
125650973 | 12565097 | Injection site erythema | |
125650973 | 12565097 | Injection site swelling | |
125650973 | 12565097 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125650973 | 12565097 | 1 | 20160610 | 0 | ||
125650973 | 12565097 | 4 | 20160701 | 20160831 | 0 |